XML 40 R4.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Revenue:      
Collaboration agreements $ 7,600 $ 135  
Operating expenses:      
Research and development, net of tax credits 90,047 40,091 $ 20,995
General and administrative 26,213 14,346 5,382
Total operating expenses 116,260 54,437 26,377
Loss from operations (108,660) (54,302) (26,377)
Other (expense) income, net      
Realized and unrealized (loss) gain on foreign exchange (144) (664) 712
Change in fair value of Series A Preferred Share tranche obligation     (1,350)
Interest income 259 240  
Other expense (41) (16) (6)
Total other (expense) income, net 74 (440) (644)
Loss before income taxes (108,586) (54,742) (27,021)
Income tax benefit (expense) 1,678 1,325 (195)
Net loss and comprehensive loss (106,908) (53,417) (27,216)
Net loss attributable to common shareholders—basic and diluted $ (106,908) $ (53,417) $ (27,216)
Net loss per share attributable to common shareholders—basic and diluted $ (2.83) $ (2.66) $ (17.81)
Weighted-average common shares outstanding—basic and diluted 37,818,115 20,045,602 1,528,374